Perioperative Antirheumatic Drug Guideline Contains Caveats
Experts say the 2022 ACR/AAHKS guideline for patients undergoing total hip or total knee arthroplasty have a number of caveats that limit the usefulness of the recommendations.
Stay updated with breaking news from Jack Cush. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts say the 2022 ACR/AAHKS guideline for patients undergoing total hip or total knee arthroplasty have a number of caveats that limit the usefulness of the recommendations.
Training the next generation of rheumatologists will involve giving and listening to more feedback as well as using new tools to boost engagement, retention, and behavioral changes.
"For you to abandon telemedicine I think is a gigantic mistake," Dr Jack Cush said.
Rheumatologists debate whether problems in the implementation of a treat-to-target approach in patients with RA stem from the metrics used to define targets or rheumatologists' efforts to use them.
Rates of patients stopping disease-modifying antirheumatic drugs (DMARDs) have begun to rise after initially falling during the pandemic, with consequent rises in the incidence of disease flares.